AQST position history
The shares of Aquestive Therapeutics (AQST) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 500,000 shares, $2.1M, 0.48% of portfolio, New
- 2024 Q2: 530,000 shares, $1.4M, 0.33% of portfolio, Add +6.0%
- 2024 Q3: 589,561 shares, $2.9M, 0.69% of portfolio, Add +11.2%
- 2024 Q4: 127,000 shares, $452K, 0.11% of portfolio, Reduce −78.5%
- 2025 Q1: 142,000 shares, $412K, 0.12% of portfolio, Add +11.8%
- 2025 Q2: 142,000 shares, $470K, 0.13% of portfolio
- 2025 Q3: 512,589 shares, $2.9M, 0.71% of portfolio, Add +261.0%
- 2025 Q4: 375,915 shares, $2.4M, 0.56% of portfolio, Reduce −26.7%
- 2026 Q1: 368,415 shares, $1.5M, 0.35% of portfolio, Reduce −2.0%
- 2026 Q2: 645,915 shares, $2.7M, 0.51% of portfolio, Add +75.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|